Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ALPN

Alpine Immune Sciences (ALPN) Stock Price, News & Analysis

Alpine Immune Sciences logo

About Alpine Immune Sciences Stock (NASDAQ:ALPN)

Advanced Chart

Key Stats

Today's Range
$64.97
$64.97
50-Day Range
$64.37
$64.97
52-Week Range
$8.33
$65.00
Volume
2 shs
Average Volume
1.92 million shs
Market Capitalization
$4.46 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ALPN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alpine Immune Sciences and its competitors with MarketBeat's FREE daily newsletter.

ALPN Stock News Headlines

Alpine Immune Sciences Inc.
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
What 11 Analyst Ratings Have To Say About Alpine Immune Sciences
Alpine Immune Sciences Inc
See More Headlines

ALPN Stock Analysis - Frequently Asked Questions

Alpine Immune Sciences, Inc. (NASDAQ:ALPN) announced its quarterly earnings results on Tuesday, November, 9th. The biotechnology company reported ($0.55) EPS for the quarter, missing analysts' consensus estimates of $0.01 by $0.56. The biotechnology company had revenue of $8.52 million for the quarter, compared to the consensus estimate of $22.30 million. Alpine Immune Sciences had a negative net margin of 65.17% and a negative trailing twelve-month return on equity of 14.86%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Alpine Immune Sciences investors own include NVIDIA (NVDA), Broadcom (AVGO), e.l.f. Beauty (ELF), Arista Networks (ANET), Disc Medicine (IRON), Jabil (JBL) and Novo Nordisk A/S (NVO).

Company Calendar

Last Earnings
11/09/2021
Today
7/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ALPN
CIK
1626199
Employees
142
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$32.18 million
Pretax Margin
-64.99%

Debt

Sales & Book Value

Annual Sales
$56.52 million
Price / Cash Flow
N/A
Book Value
$4.85 per share
Price / Book
13.40

Miscellaneous

Free Float
39,581,000
Market Cap
$4.46 billion
Optionable
Optionable
Beta
0.97
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:ALPN) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners